Sun Pharma Advanced Research Co. Ltd.NSE: SPARC

Press Release Nov 18 2022

· Issued by Sun Pharma Advanced Research Co. Ltd.

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-nov-18-2022-8

Sun Pharma Advanced Research Company Limited has informed the Exchange about press release dated 18-Nov-2022 titled Press Release: SEZABY TM (phenobarbital sodium powder for injection) approved by US FDA for the treatment of neonatal seizures

View Attachment

6ix hasn’t read this filing yet.

Sun Pharma Advanced Research Co. Ltd. on 6ix

Earlier from Sun Pharma Advanced Research

Later from Sun Pharma Advanced Research

All Sun Pharma Advanced Research news releases